USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: XECHEM, INC.
City: NEW BRUNSWICK
State: NJ
Zip+4: 08901
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (732) 247-3300

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $845,739.00 6

Award List:

DEVELOPMENT OF HYDROHEPTIN, AN ANTIFUNGAL ANTIBIOTIC

Award Year / Program / Phase: 1992 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ramesh C Pandey
Award Amount: $49,680.00
Abstract:
The incidence of fungal infection has been steadily increasing among immunosuppressed and cancer patients. for this reason, there is a need for an effective, non-toxic water soluble antifungal agent. the objective of this research is to prepare and characterize the novel antifungal antibiotic… More

HYBRID PROCESSOR FOR PHYSIOLOGICAL ARTIFACT DETECTION HYBRID PROCESSOR FOR PHYSIOLOGICAL ARTIFACT DETECTION

Award Year / Program / Phase: 1992 / SBIR / Phase I
Agency: NASA
Principal Investigator:
Award Amount: $49,680.00

ENHANCED XECHEM INTEGRATED SCREENING TECHNIQUE (EXISTTM)

Award Year / Program / Phase: 1996 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $86,742.00

BIOACTIVE NATURAL PRODUCTS FROM MARINE EXTREMOPHILES

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ramesh C. Pandey
Award Amount: $87,084.00
Abstract:
Not Available An autonomous field of sensor nodes needs to acquire and track targets of interest traversing the field. Small detection ranges limit the detectability of the field. As detections occur in the field, detections are transmitted acoustically to a master node. Both detection processing… More

NIPRISAN FOR TREATING PATIENTS WITH SICKLE CELL DISEASE

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ramesh C. Pandey
Award Amount: $99,372.00
Abstract:
DESCRIPTION (provided by applicant): Sickle Cell Disease (SCD) is a hereditary blood disorder caused by an abnormal hemoglobin called sickle hemoglobin (Hb S). Although the Hb S of patients with SCD in the steady state can transport oxygen like normal hemoglobin, Hb S forms rigid fibers when the… More

Toxicity Studies of Potent Antisickling Agent 5HMF

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ramesh C. Pandey
Award Amount: $473,181.00
Abstract:
DESCRIPTION (provided by applicant): Sickle cell disease (SCD) is a hereditary blood disorder, affecting millions of patients worldwide, leading to high medical costs and a shortened life expectancy. Although many approaches to prevent the symptoms of sickle cell disease (SCD) have been and… More